Form 8-K - Current report:
SEC Accession No. 0001079973-12-000478
Filing Date
2012-06-20
Accepted
2012-06-20 17:08:16
Documents
4
Period of Report
2012-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k.htm 8-K 33446
2 EXHIBIT 1.1 ex1x1.htm EX-1.1 431398
3 EXHIBIT 3.1 ex3x1.htm EX-3.1 46334
4 EXHIBIT 99.1 ex99x1.htm EX-99.1 14572
  Complete submission text file 0001079973-12-000478.txt   527037
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 12917883
SIC: 2835 In Vitro & In Vivo Diagnostic Substances